Tristel (LON:TSTL)
396p+0.51%
Spriggl Score: Strong— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“US growth explodes 542% as new CEO starts; premium price reflects durable moat.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Tristel
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfe…
- Sector:
- Healthcare
- Industry:
- Medical Instruments & Supplies
- Market Cap:
- £186.0M
Recent dividends
- 19 Mar 20265.68p
- 27 Nov 20258.52p
- 20 Mar 20255.68p
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Tristel and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free